• Users Online: 1305
  • Home
  • Print this page
  • Email this page

    Article Cited by others

BRIEF COMMUNICATION

One day wonder: Fast resolution of macular edema following intravitreal ranibizumab in retinal venous occlusions

Verma Lalit, Chakravarti Arindam, Gupta Avnindra, Prakash Smriti

Year : 2013| Volume: 61| Issue : 9 | Page no: 528-530

   This article has been cited by
 
1 Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
Bhim Bahadur Rai, Deepa Rai, Ted Maddess
Clinical Ophthalmology. 2023; Volume 17: 1565
[Pubmed]  [Google Scholar] [DOI]
2 A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
Shashikant Sharma, Manjunath Bhaskar Anandkumar, Sangita Jain, Hemanth Murthy, Naveenam Srinivasa Murlidhar, Raj Shri Hirawat, Aditya Sudhalkar, Amarendra Deka, Alay Banker, Vatsal Parikh, Manisha Agarwal, Charu Mithal, Rajender Pal Singh, Deepti Kulkarni, Abhishek Desai, Rushikesh Naigaonkar, Nishikant Borse, Simanta Pradeep Saikia, Atul Kumar Sahu, Shobhna Mange, Arup Chakraborty, Suprakash Roy, Valensha Surong, Mujtaba Khan, Alok Chaturvedi
Ophthalmology and Therapy. 2020; 9(3): 625
[Pubmed]  [Google Scholar] [DOI]
3 Changing paradigms of anti-VEGF in the Indian scenario
Shanmugam, P.M.
Indian Journal of Ophthalmology. 2014; 62(1): 88-92
[Pubmed]  [Google Scholar]

 

Read this article